Private versus public sector insurance coverage for drug abuse / Jeannette A. Rogowski.

Format:

Book

Author/Creator:

Rogowski, Jeannette A.

Contributor:

Drug Policy Research Center (U.S.)

Language:

English

Subjects (All):

Health insurance--United States.

Health insurance.

Drug abuse--Treatment--United States--Finance.

Drug abuse.

Medicaid.

Medicare.

United States. Office of Civilian Health and Medical Program of the Uniformed Services.

United States.

Physical Description:

1 online resource (xi, 53 pages) : illustrations

Place of Publication:

Santa Monica, CA : RAND Corporation, 1993.

Summary:

This study examined financing mechanisms currently in place for treating drug abuse, focusing primarily on differences between private and public insurance mechanisms. Within the private sector, insurance coverage for drug abuse treatment is quite restrictive. Limitations typically exist on the type and amount of treatment that can be received per year or per lifetime, and benefits may quickly be exhausted. Limitations also exist with regard to public insurance funding. Eligibility requirements and the authorized settings in which care may be provided are extremely restrictive. It has been argued that public funding for drug abuse should be mainstreamed into Medicaid. However, this is not likely to occur due to significant institutional barriers, and in particular to the highly restrictive eligibility requirements for public programs.

Notes:

"Drug Policy Research Center."